The Canadian Technician

Knight Therapeutics Sees Daylight (GUD.TO)

Greg Schnell

Greg Schnell

Chief Technical Analyst, Osprey Strategic

Knight Therapeutics (GUD.TO) has broken out to new all time highs since its 2014 IPO. Why is this important? Well any investor currently holding the stock is in a profit position. This means they are less likely to sell their winners. 


Secondly, the price action has pushed the SCTR ranking to 92 in November. The MACD looks to be pushing to new 18-month highs which suggests the momentum is better than it has been in a long time. There have been lots of above average green volume candles in the last 3 weeks (Zoombox) suggesting that the interest level is picking up. Also, the relative strength in purple is breaking out to higher highs. That brings in more institutional investors as the stock moves above $10 as well. 

This looks good for Canadian investors. You'll still have to manage the trade, but this is setting up nicely.

Good trading, 
Greg Schnell, CMT, MFTA.

Greg Schnell
About the author: , CMT, MFTA is Chief Technical Analyst at Osprey Strategic specializing in intermarket and commodities analysis. He is also the co-author of Stock Charts For Dummies (Wiley, 2018). Based in Calgary, Greg is a board member of the Canadian Society of Technical Analysts (CSTA) and the chairman of the CSTA Calgary chapter. He is an active member of both the CMT Association and the International Federation of Technical Analysts (IFTA). Learn More